We are live on ! Find out more
PALI icon

Palisade Bio
PALI

96 hedge funds and large institutions have $262M invested in Palisade Bio in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 20

20% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 25

12% more funds holding

Funds holding: 86 → 96 (+10)

1.07% less ownership

Funds ownership: 91.19% → 90.12% (-1.1%)

18% less capital invested

Capital invested by funds: $319M → $262M (-$57.6M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
96
Holders Change
+10
Holders Change %
+11.63%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
31
Increased
30
Reduced
25
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BGI
B Group Inc
Texas
+$12.6M
2
Goldman Sachs
Goldman Sachs
New York
+$8.76M
3
Ameriprise
Ameriprise
Minnesota
+$8.36M
4
GPP
Great Point Partners
Connecticut
+$6.19M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$5.7M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$18.3M
2
SC
Stempoint Capital
New York
-$9.85M
3
CC
Commodore Capital
New York
-$7.75M
4
PA
Perceptive Advisors
New York
-$5.68M
5
VC
Vivo Capital
California
-$5.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
26
BlackRock
New York
$3.28M -$5.42K -2,979 -0.2%
SFM
27
Sphera Funds Management
Israel
$3.03M +$2.82M +1,549,371 +842%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$2.71M -$34.9K -19,212 -1%
Renaissance Technologies
29
Renaissance Technologies
New York
$2.55M -$1.69M -928,100 -39%
VCM
30
Vanguard Capital Management
Pennsylvania
$2.5M +$2.6M +1,429,308 New
PIM
31
Platinum Investment Management
Australia
$2.15M +$1.03M +567,327 +85%
UBS Group
32
UBS Group
Switzerland
$2.04M +$1.67M +919,197 +371%
PBM
33
Propel Bio Management
California
$2M +$2.03M +1,115,000 New
Aberdeen Group
34
Aberdeen Group
United Kingdom
$1.16M +$1.21M +662,900 New
VFT
35
Vanguard Fiduciary Trust
Pennsylvania
$1.15M +$1.2M +659,289 New
State Street
36
State Street
Massachusetts
$1.11M -$14.2K -7,800 -1%
EAM
37
Exome Asset Management
New York
$1.05M -$288K -158,203 -21%
CDMG
38
Creek Drive Management Group
California
$945K +$423K +232,500 +76%
Point72 Asset Management
39
Point72 Asset Management
Connecticut
$721K -$18.3M -10,083,480 -96%
Jane Street
40
Jane Street
New York
$719K +$122K +67,075 +20%
SAM
41
Simplify Asset Management
Nevada
$613K +$636K +350,000 New
LCM
42
Landscape Capital Management
New Jersey
$569K +$591K +325,019 New
Northern Trust
43
Northern Trust
Illinois
$491K -$4.54K -2,497 -0.9%
IC
44
Ikarian Capital
Texas
$481K – – –
ACM
45
ACT Capital Management
Pennsylvania
$451K +$195K +107,500 +72%
PAP
46
Persistent Asset Partners
Hong Kong
$414K -$327K -179,687 -43%
BHCM
47
Brevan Howard Capital Management
Jersey
$376K +$391K +214,821 New
SFCM
48
Seven Fleet Capital Management
California
$373K -$208K -114,400 -35%
HF
49
HRT Financial
New York
$370K +$385K +211,882 New
XT
50
XTX Topco
Cayman Islands
$358K +$333K +182,921 +844%
1
2
3 4 5

PALI Hedge Fund Activity: Q1 2026 in Review

96 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2026, worth a combined $262M — down 18% from $319M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PALI positions and 20 closed out — a net gain of 11 holders — while 30 added to existing stakes and 25 trimmed.

The largest buyer was B Group Inc, adding an estimated $12.6M. The largest seller was Point72 Asset Management, cutting an estimated $18.3M.

  • 96 institutional investors held Palisade Bio (PALI) as of Q1 2026, up from 86 in Q4 2025.
  • Funds reported $262M of Palisade Bio stock for Q1 2026, down 18% quarter-over-quarter.
  • 31 funds opened new Palisade Bio positions in Q1 2026 and 20 closed out, a net change of +11 holders.
  • The largest Palisade Bio buyer in Q1 2026 was B Group Inc, an estimated $12.6M added.
  • The largest Palisade Bio seller in Q1 2026 was Point72 Asset Management, an estimated $18.3M sold.

Based on aggregated 13F filings for Q1 2026.